Global DNA Microarray Market 2016-2020

SKU ID :TNV-10280169 | Published Date: 30-Sep-2016 | No. of pages: 75
PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Vendor analysis • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights • Market size and forecast • Five forces analysis PART 05: Market landscape • Market overview PART 06: Market segmentation by application • Market overview PART 07: Market segmentation by product type • Market overview • Global DNA microarray consumables market • Global DNA microarray instruments market PART 08: Geographical segmentation • Market overview • DNA microarray market in Americas • DNA microarray market in EMEA • DNA microarray market in APAC PART 09: Market drivers PART 10: Impact of drivers PART 11: Market challenges PART 12: Impact of drivers and challenges PART 13: Market trends PART 14: Vendor landscape • Competitive scenario PART 15: Key vendor analysis • Agilent Technologies • Illumina • Merck • Thermo Fisher Scientific • Other prominent vendors PART 16: Appendix • List of abbreviations PART 17: Explore Technavio List of Exhibits Exhibit 01: Key countries Exhibit 02: Global DNA microarray market segmentation: Overview Exhibit 03: Product offerings Exhibit 04: Global DNA microarray market: Overview Exhibit 05: Growth perspective in developed and developing markets Exhibit 06: Revenue comparison of DNA microarray and global microarray market ($ billions) Exhibit 07: Global DNA microarray market 2015-2020 ($ billions) Exhibit 08: Impact of various factors on the global DNA microarray market Exhibit 09: Five forces analysis Exhibit 10: Applications of DNA microarrays Exhibit 11: Snapshot of global DNA microarray market Exhibit 12: Global DNA microarray market segmentation by application 2015 and 2020 Exhibit 13: Global DNA microarray market 2015-2020 (% share) Exhibit 14: Snapshot: Global DNA microarray market by application Exhibit 15: Global DNA microarray market in gene expression segment 2015-2020 ($ millions) Exhibit 16: Global DNA microarray market in disease diagnosis and drug development segment 2015-2020 ($ millions) Exhibit 17: Global DNA microarray market in others segment 2015-2020 ($ millions) Exhibit 18: Global DNA microarray market by product type 2015 and 2020 Exhibit 19: Global DNA microarray market: Opportunity analysis Exhibit 20: Global DNA microarray consumables market 2015-2020 ($ billions) Exhibit 21: Global DNA microarray instruments market 2015-2020 ($ millions) Exhibit 22: Value-chain of DNA microarray instruments Exhibit 23: Global DNA microarray market by geography 2015-2020 Exhibit 24: Snapshot of geographical segmentation 2015-2020 Exhibit 25: DNA microarray market in Americas 2015-2020 ($ billions) Exhibit 26: DNA microarray market in EMEA 2015-2020 ($ millions) Exhibit 27: DNA microarray market in APAC 2015-2020 ($ billions) Exhibit 28: Major chronic disease-related deaths 2012 (thousands) Exhibit 29: Impact of drivers Exhibit 30: Impact of drivers and challenges Exhibit 31: Global cancer cases and deaths 2012 and 2030 Exhibit 32: Regional growth in R&D spending in the biomedical sector 2010-2015 Exhibit 33: Strategic success factors of companies Exhibit 34: Competitive parameters in global DNA microarray market Exhibit 35: Agilent Technologies: Profile Exhibit 36: Agilent Technologies: Strength analysis Exhibit 37: Agilent Technologies growth strategy matrix Exhibit 38: Agilent Technologies: Opportunity assessment Exhibit 39: Illumina profile Exhibit 40: Illumina: Strength analysis Exhibit 41: Illumina: Growth strategy matrix Exhibit 42: Illumina: Opportunity assessment Exhibit 43: Merck: Profile Exhibit 44: Merck: Strength analysis Exhibit 45: Merck: Growth strategy matrix Exhibit 46: Merck: Opportunity assessment Exhibit 47: Thermo Fisher Scientific: Profile Exhibit 48: Thermo Fisher Scientific: Strength analysis Exhibit 49: Thermo Fisher Scientific: Growth strategy matrix Exhibit 50: Thermo Fisher Scientific: Opportunity assessment
Agilent Technologies, Illumina, Merck, Thermo Fisher Scientific, Applied Microarrays, Arrayit, AXO Science, BioCat, BioGenex Laboratories, Biometrix Technology, Cepheid, GE Healthcare, InDevR, LC Sciences, PerkinElmer, Phalanx Biotech, QIAGEN, Takara Bio, US Biomax.
  • PRICE
  • $2500
    $4000

Our Clients